Dolores J. Lamb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dolores J. Lamb has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Kathleen Hwang
Department of Surgery (Urology), The Alpert Medical School of Brown University, Providence, RI, USA
4 shared publicationsMaria Rosa Maduro
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA
3 shared publicationsLarry I. Lipshultz
Scott Department of Urology, Division of Male Reproductive Medicine and Surgery, Baylor College of Medicine, Houston, USA
2 shared publications- Larry I. Lipshultz
From the Scott Department of Urology, Baylor College of Medicine, Houston, Texas
2 shared publications Alan Davis
1 shared publicationAlex Ridgeway
1 shared publication
Latest Publications
- 1 March 2015
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 92 (3) , 76
Ghrelin Partially Protects Against Cisplatin-Induced Male Murine Gonadal Toxicity in a GHSR-1a-Dependent Manner1
The chemotherapeutic drug cisplatin causes a number of dose-dependent side effects, including cachexia and testicular damage. Patients receiving a high cumulative dose of cisplatin may develop permanent azoospermia and subsequent infertility. Thus, the development of chemotherapeutic regimens with the optimal postsurvival quality of life (fertility) is of high importance. This study tested the hypothesis that ghrelin administration can prevent or minimize cisplatin-induced testicular damage and cachexia. Ghrelin and its receptor, the growth hormone secretagogue receptor (GHSR-1a), are expressed and function in the testis. Targeted deletion of ghrelin, or its receptor, significantly increases the rate of cell death in the testis, suggesting a protective role. Intraperitoneal administration of vehicle, ghrelin, or cisplatin alone or in combination with ghrelin, in cycles of 9 or 18 days, to adult male C57Bl/6 mice was performed. Body weight was measured daily and testicular and epididymal weight, sperm density and motility, testicular histology, and testicular cell death were analyzed at the time of euthanization. Ghrelin coadministration decreased the severity of cisplatin-induced cachexia and gonadal toxicity. Body, testicular, and epididymal weights significantly increased as testicular cell death decreased with ghrelin coadministration. The widespread damage to the seminiferous epithelium induced by cisplatin administration was less severe in mice simultaneously treated with ghrelin. Furthermore, ghrelin diminished the deleterious effects of cisplatin on testis and body weight homeostasis in wild-type but not Ghsr(-/-) mice, showing that ghrelin's actions are mediated via GHSR. Ghrelin or more stable GHSR agonists potentially offer a novel therapeutic approach to minimize the testicular damage that occurs after gonadotoxin exposure.
- 1 March 2015
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 92 (3) , 76
Ghrelin Partially Protects Against Cisplatin-Induced Male Murine Gonadal Toxicity in a GHSR-1a-Dependent Manner1
The chemotherapeutic drug cisplatin causes a number of dose-dependent side effects, including cachexia and testicular damage. Patients receiving a high cumulative dose of cisplatin may develop permanent azoospermia and subsequent infertility. Thus, the development of chemotherapeutic regimens with the optimal postsurvival quality of life (fertility) is of high importance. This study tested the hypothesis that ghrelin administration can prevent or minimize cisplatin-induced testicular damage and cachexia. Ghrelin and its receptor, the growth hormone secretagogue receptor (GHSR-1a), are expressed and function in the testis. Targeted deletion of ghrelin, or its receptor, significantly increases the rate of cell death in the testis, suggesting a protective role. Intraperitoneal administration of vehicle, ghrelin, or cisplatin alone or in combination with ghrelin, in cycles of 9 or 18 days, to adult male C57Bl/6 mice was performed. Body weight was measured daily and testicular and epididymal weight, sperm density and motility, testicular histology, and testicular cell death were analyzed at the time of euthanization. Ghrelin coadministration decreased the severity of cisplatin-induced cachexia and gonadal toxicity. Body, testicular, and epididymal weights significantly increased as testicular cell death decreased with ghrelin coadministration. The widespread damage to the seminiferous epithelium induced by cisplatin administration was less severe in mice simultaneously treated with ghrelin. Furthermore, ghrelin diminished the deleterious effects of cisplatin on testis and body weight homeostasis in wild-type but not Ghsr(-/-) mice, showing that ghrelin's actions are mediated via GHSR. Ghrelin or more stable GHSR agonists potentially offer a novel therapeutic approach to minimize the testicular damage that occurs after gonadotoxin exposure.
- 21 February 2013
- Published by Cambridge University Press (CUP)
- p. 11-22
Spermatogenesis
- Open Access
- 9 August 2012
- Published by Springer Nature
- Vol. 927, 103-111
The Sperm Penetration Assay for the Assessment of Fertilization Capacity
The sperm penetration assay, or zona-free hamster oocyte penetration assay, is utilized to measure the ability of sperm to undergo capacitation, fuse with the egg membrane, and decondense the sperm head within the cytoplasm of the oocyte, resulting in the formation of the male pronucleus. The test is scored by calculation of the percentage of ova that are penetrated (the original assay developed) or the average number of sperm penetrations per ovum (the sperm capacitation index of the optimized assay). The sperm penetration assay identifies those couples that will have a high likelihood of success with in vitro fertilization.
- 9 August 2012
- Published by Springer Nature
- Vol. 927, 103-111
Open AccessThe Sperm Penetration Assay for the Assessment of Fertilization Capacity
The sperm penetration assay, or zona-free hamster oocyte penetration assay, is utilized to measure the ability of sperm to undergo capacitation, fuse with the egg membrane, and decondense the sperm head within the cytoplasm of the oocyte, resulting in the formation of the male pronucleus. The test is scored by calculation of the percentage of ova that are penetrated (the original assay developed) or the average number of sperm penetrations per ovum (the sperm capacitation index of the optimized assay). The sperm penetration assay identifies those couples that will have a high likelihood of success with in vitro fertilization.
- 23 December 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 95 (2) , 488
Diagnostic testicular biopsy before varicocele repair plays a realistic and important role
- 23 December 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 95 (2) , 488
Diagnostic testicular biopsy before varicocele repair plays a realistic and important role
- 19 November 2010
- Published by Springer Nature in Current Urology Reports
- Vol. 12 (1) , 68-76
Use of Diagnostic Testing to Detect Infertility
The evaluation of the infertile male continues to be a clinical challenge of increasing significance with considerable emotional and financial burdens. Many physiological, environmental and genetic factors are implicated; however, the etiology of suboptimal semen quality is poorly understood. This review focuses on the diagnostic testing currently available, as well as future directions that will be helpful for the practicing urologist and other clinicians to fully evaluate the infertile male.
- 19 November 2010
- Published by Springer Nature in Current Urology Reports
- Vol. 12 (1) , 68-76
Use of Diagnostic Testing to Detect Infertility
The evaluation of the infertile male continues to be a clinical challenge of increasing significance with considerable emotional and financial burdens. Many physiological, environmental and genetic factors are implicated; however, the etiology of suboptimal semen quality is poorly understood. This review focuses on the diagnostic testing currently available, as well as future directions that will be helpful for the practicing urologist and other clinicians to fully evaluate the infertile male.
- Open Access
- 6 September 2010
- Published by Medknow in Asian Journal of Andrology
- Vol. 12 (6) , 787-789
In vivo exploration of the functional activity of the non-coding 8q24 prostate cancer risk locus
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.
- 6 September 2010
- Published by Medknow in Asian Journal of Andrology
- Vol. 12 (6) , 787-789
Open AccessIn vivo exploration of the functional activity of the non-coding 8q24 prostate cancer risk locus
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.
- 18 June 2010
- Published by SAGE Publications in Therapeutic Advances in Urology
- Vol. 2 (4) , 157-169
The use of fluorescent in situ hybridization in male infertility
Male factors are implicated in up to 50% of couples being evaluated and treated for infertility with advanced assisted reproductive technologies. Genetic abnormalities, including sperm chromosome aneuploidy as well as structural aberrations, are one of the major causes of infertility. The use of chromosome-specific DNA probes labeled with fluorochromes, particularly the combination with multiple probes, has been used to indirectly study the sperm chromosome by fluorescent in situ hybridization (FISH). Clinically, this technique is also used to assess the sperm of men recovering from gonadotoxic treatment. Recent advances in this technology facilitate the evaluation of sperm aneuploidy. Sperm FISH is a widely used screening tool to aid in counseling couples with severe male factor infertility, especially in cases of prior repeated in vitro fertilization/intracytoplasmic sperm injection failure or recurrent pregnancy loss. Automation of FISH imaging and analysis, as well as the development of emerging techniques such as comparative genomic hybridization, will all contribute to the promise of future diagnostic approaches aimed at improving the quality, ease, and efficiency of aneuploidy analysis.
- 18 June 2010
- Published by SAGE Publications in Therapeutic Advances in Urology
- Vol. 2 (4) , 157-169
The use of fluorescent in situ hybridization in male infertility
Male factors are implicated in up to 50% of couples being evaluated and treated for infertility with advanced assisted reproductive technologies. Genetic abnormalities, including sperm chromosome aneuploidy as well as structural aberrations, are one of the major causes of infertility. The use of chromosome-specific DNA probes labeled with fluorochromes, particularly the combination with multiple probes, has been used to indirectly study the sperm chromosome by fluorescent in situ hybridization (FISH). Clinically, this technique is also used to assess the sperm of men recovering from gonadotoxic treatment. Recent advances in this technology facilitate the evaluation of sperm aneuploidy. Sperm FISH is a widely used screening tool to aid in counseling couples with severe male factor infertility, especially in cases of prior repeated in vitro fertilization/intracytoplasmic sperm injection failure or recurrent pregnancy loss. Automation of FISH imaging and analysis, as well as the development of emerging techniques such as comparative genomic hybridization, will all contribute to the promise of future diagnostic approaches aimed at improving the quality, ease, and efficiency of aneuploidy analysis.
- Open Access
- 1 January 2010
- Published by Medknow in Asian Journal of Andrology
- Vol. 12 (1) , 64-70
Semen analysis in 21st century medicine: the need for sperm function testing
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.
- 1 January 2010
- Published by Medknow in Asian Journal of Andrology
- Vol. 12 (1) , 64-70
Open AccessSemen analysis in 21st century medicine: the need for sperm function testing
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.
- Top Cited Papers
- 6 November 2008
- Published by Springer Nature in Nature Medicine
- Vol. 14 (11) , 1197-1213
The biology of infertility: research advances and clinical challenges
Reproduction is required for the survival of all mammalian species, and thousands of essential 'sex' genes are conserved through evolution. Basic research helps to define these genes and the mechanisms responsible for the development, function and regulation of the male and female reproductive systems. However, many infertile couples continue to be labeled with the diagnosis of idiopathic infertility or given descriptive diagnoses that do not provide a cause for their defect. For other individuals with a known etiology, effective cures are lacking, although their infertility is often bypassed with assisted reproductive technologies (ART), some accompanied by safety or ethical concerns. Certainly, progress in the field of reproduction has been realized in the twenty-first century with advances in the understanding of the regulation of fertility, with the production of over 400 mutant mouse models with a reproductive phenotype and with the promise of regenerative gonadal stem cells. Indeed, the past six years have witnessed a virtual explosion in the identification of gene mutations or polymorphisms that cause or are linked to human infertility. Translation of these findings to the clinic remains slow, however, as do new methods to diagnose and treat infertile couples. Additionally, new approaches to contraception remain elusive. Nevertheless, the basic and clinical advances in the understanding of the molecular controls of reproduction are impressive and will ultimately improve patient care.
- 6 November 2008
- Published by Springer Nature in Nature Medicine
- Vol. 14 (11) , 1197-1213
Top Cited PapersThe biology of infertility: research advances and clinical challenges
Reproduction is required for the survival of all mammalian species, and thousands of essential 'sex' genes are conserved through evolution. Basic research helps to define these genes and the mechanisms responsible for the development, function and regulation of the male and female reproductive systems. However, many infertile couples continue to be labeled with the diagnosis of idiopathic infertility or given descriptive diagnoses that do not provide a cause for their defect. For other individuals with a known etiology, effective cures are lacking, although their infertility is often bypassed with assisted reproductive technologies (ART), some accompanied by safety or ethical concerns. Certainly, progress in the field of reproduction has been realized in the twenty-first century with advances in the understanding of the regulation of fertility, with the production of over 400 mutant mouse models with a reproductive phenotype and with the promise of regenerative gonadal stem cells. Indeed, the past six years have witnessed a virtual explosion in the identification of gene mutations or polymorphisms that cause or are linked to human infertility. Translation of these findings to the clinic remains slow, however, as do new methods to diagnose and treat infertile couples. Additionally, new approaches to contraception remain elusive. Nevertheless, the basic and clinical advances in the understanding of the molecular controls of reproduction are impressive and will ultimately improve patient care.
- Open Access
- 14 October 2008
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 5 (11) , 594-595
Would gene therapy for the treatment of male infertility be safe?
- 14 October 2008
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 5 (11) , 594-595
Open AccessWould gene therapy for the treatment of male infertility be safe?